Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Rouka (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zarogiannis (Larissa, Greece). Antibody epitope and mimotope prediction of the viroporins M2 of the Influenza A virus, E of the Human SARS coronavirus and SH of the Respiratory Syncytial virus.. 2387

Member's Comments

No comment yet.

Related content which might interest you: Respiratory syncytial virus Source: Eur Respir Monogr 2016; 72: 84-109 Year: 2016 The first H7N9 influenza case of Shanghai in 2014: Reemerged virus with different origin of PB2 gene Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Severe influenza virus H1N1: Lung pathology Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology Year: 2010 Respiratory syncytial virus (RSV) prophylaxis in special populations Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions Year: 2011 Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation Source: Eur Respir J 2011; 37: 44-52 Year: 2011 Abortive replication and reactivation in vitro respiratory syncytial virus (RSV) infection in palivizumab-treated HeLa cells Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Dual infection of infants by human metapneumovirus (hMPV) and human respiratory syncytial virus (hRSV) is strongly associated with severe bronchiolitis Source: Annual Congress 2004 - Viral bronchiolitis in children: what's new in diagnosis and treatment? Year: 2004 Clinical and epidemiological features in H1N1 and H3N2 influenza A virus Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 Persistence of respiratory syncytial virus replication in lung dendritic cells Source: International Congress 2015 – Paediatric pulmonary infections Year: 2015 Trans-placental transmission of the respiratory syncytial virus Source: International Congress 2015 – Paediatric pulmonary infections: mechanisms and treatment Year: 2015 Impact of the COVID-19 pandemic on Influenza virus transmission Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Respiratory syncytial virus: a common threat Source: Annual Congress 2011 - PG17 Emerging infections: educational perspectives Year: 2011 Rapid spread of the novel respiratory syncytial virus A ON1 genotype, during the epidemic seasons 2011-2013 Source: International Congress 2014 – Virus-triggered lower respiratory disease in children Year: 2014 COVID-19 vaccination and more Source: ERS webinar 2021: COVID-19 vaccination and more Year: 2021 Respiratory syncytial virus and metapneumovirus in Brazilian infants: PCR, genotypes and clinical data Source: Annual Congress 2008 - Miscellaneous respiratory infections Year: 2008 The role of neutrophils in viral clearance during respiratory syncytial virus (RSV) disease Source: Annual Congress 2013 –Pulmonary infection in children: diagnosis and long-term effects Year: 2013 Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015 Influenza Source: ERS Course 2018 - Respiratory Infections Year: 2018 Respiratory morbidity after hospitalisation with Respiratory Syncytial Virus and Rhinovirus infection. Source: International Congress 2017 – Paediatric respiratory infections and immunity Year: 2017